Since folks want to throw Cory under the bus...

[OneBlueDotBama]

70. Trying to keep track of....

What company has a license to sell this drug and another license to sell the same drug in another country under a different brand name is a monumental task at best.

With Insulin, Banting and his group sold the patent to the U of T for a dollar, for the good of mankind.

As for Shkreli, there is an area where drug compounders like Three Rivers should step in as they have in the past for HCV meds.

The biggest problem is big pharma will not let go of their cash cow and they have the money to ensure things remain favorable to them.

Toss in big pharma has a nasty habit of dropping cohorts from their trials when they don't respond to their med and generally just say they left the trial, meaning the info the FDA or whomever the org is that tests for safety has faulty info to work with.

Having worked in the industry in Canada and the US, I'm personally often sickened by what big pharma gets away with on many levels, from drug development, to trials, to un-sterile manufacturing facilities to pricing and not to forget marketing.